Abstract
It is increasingly recognised that drug abuse not only contributes to the trauma patient population but also that the effects of acute and chronic drug toxicity have major implications for patient management. The role of drug abuse as a factor associated with morbidity and mortality in the trauma setting has not been properly quantified. Physicians dealing with victims of acute trauma will however, inevitably have to deal with the associated problems of drug abuse. For optimal management of these patients a thorough working knowledge of commonly abused drugs is required.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Government Statistical Service (1997) Statistical bulletin. Department of Health, p 1.
Kirby JM, Maull KI, Fain W (1992) Comparability of alcohol and drug use in injured drivers. Southern Med Journal 85:800–801.
Lindenbaum GA, Carrol SF, Daskal I et al (1989) Patterns of alcohol and drug abuse in an urban trauma center: the increasing role of cocaine abuse. J Trauma 29:1654–1658.
Soderstrom CA, Dischinger PC, Smith GS et al (1992) Psychoactive substance dependence among trauma center patients. JAMA 267:2756–2759
Department of Transport (1997) News release, press notice 149/Transport.
Galbraith S (1976) Misdiagnosis and delayed diagnosis of traumatic intracranial haematoma. British Medical Journal 1:1438.
Abelson HI, Miller JD (1985) A decade in trends in cocaine use in the household population. Nat Inst Drug Abuse Res Monogr Ser 61:35–49.
Marzuk PM, Tardiff K, Leon AC et al (1995) Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Eng J Med 26:1753.
Pasternack PF, Colvin SE, Baumann FG (1985) Cocaine induced angina pectoris and myocardial infarction in patients younger than 40 years. Am J Cardiol 55:847.
Isner JM, Estes M, Thompson PD et al (1986) Acute cardiac events temporarily related to cocaine abuse. N Engl J Med 315:1438.
Barth CW, Bray M, Roberts WC (1986) Rupture of the ascending aorta during cocaine intoxication. Am J Cardiol 57:496.
Chokshi SK, Moore R, Pondion NG et al (1989) Reversible cardiomyopathy associated with cocaine intoxication. Ann Intern Med 111:1039.
Lange RA, Cigarroa RG, Yancy CW Jr et al (1989) Cocaine induced coronary artery vasoconstriction. N Eng J Med 321:1557–1562.
Cregler LL, Mark H (1986) Cardiovascular dangers of cocaine abuse. Am J Cardiol 57:1185.
Lange RA, Cigarroa RG, Flores ED et al (1990) Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 112:897–903.
Ramoska E, Sacchetti AD (1985) Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med 14:1112.
Gay GR, Loper KA (1988) The use of labetolol in the management of cocaine crisis. Ann Emerg Med 17:282–283.
Dusenberry SJ, Hicks MJ, Mariani PJ (1987) Labetalol treatment of cocaine toxicity. Ann Emerg Med 16:235.
Pollan S, Tadjziechy M (1989) Esmolol in the management of epinephrine and cocaine induced cardiovascular toxicity. Anesth Analg 69:663–664.
Derlet RW, Albertson TE (1990) Potentiation of cocaine toxicity with lidocaine. Ann Emerg Med 19:464.
Itkonen J, Schnoll S, Glassroth J (1984) Pulmonary dysfunction in “freebase” cocaine users. Arch Int Med 144:2195.
Shesser R, Davis C, Edelsten S (1981) Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine. Ann Emerg Med 10:213.
Patal RC, Dutta D, Schonfeld SA (1987) Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Intern Med 107:186.
Campbell D, Parr MJA, Shutt LE (1996) Unrecognised crack cocaine abuse in pregnancy. Br J Anaesthesia 77:553–555.
Derlet RW, Albertson TE (1986) Emergency department presentation of cocaine intoxication. Ann Emerg Med 18:182.
Seaman ME (1990) Acute cocaine abuse associated with cerebral infarction. Ann Emerg Med 19:34.
Lichtenfeld PJ, Rubin DB, Feldman RS (1984) Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol 411:223.
Peterson PL, Roszler M, Jacobs I et al (1991) Neurovascular complications of cocaine abuse. J Neuropsychiat Clin Neurosci 3:143.
Kay BR, Fainstate M (1987) Cerebral vasculitis associated with cocaine abuse. JAMA 258:2104.
Myers JA, Barnett MF (1984) Generalized seizures and cocaine abuse. Neurology 344:1675.
Merigian KS, Roberts JR (1987) Cocaine intoxication: hyperyrexia, rhabdomyolysis, and acute renal failure. Clin Toxicol 25:135.
Perinol LE, Warren GE, Levine JS (1987) Cocaine induced hepatoxicity in humans. Gastroenterology 93:176.
Stoelting RK, Creassor CW, Martz RC (1975) Effects of cocaine on halothane MAC in dogs. Anesth Analg 54:422.
Matera C, Warren WB, Moomjy M et al (1990) Prevalence of the use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 163:797.
Woods JR, Plessinger MA, Clark KE (1987) Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257:957.
Derlet RW, Albertson TE (1989) Agents that protect against cocaine induced death and seizures. Ann Emerg Med 18:446.
Goetting MG (1985) Neurotoxicity of meperidine. Ann Emerg Med 14:1007.
Stone PA, MacIntyre PE, Jarvis DA (1993) Norpethidine toxicity and patient controlled analgesia. BJA 71:738–740.
Duberstein JL, Kaufman DM (1971) A clinical study of an epidemic of heroin intoxication and heroin induced pulmonary oedema. Am J Med 51:704
National Safety Council (1996) Accident facts. National Safety Council, Itasca.
Goldfrank LR (1984) The several uses of naloxone. Emerg Med 16:105.
Tandberg D, Abercrombie D (1982) Treatment of heroin overdosage with endotracheal naloxone. Ann Emerg Med 11:443.
George CF, Robertson D (1987) Clinical consequences of abrupt drug withdrawal. Med Toxicol 2:367.
Gossop M (1988) Clonidine and the treatment of the opioid withdrawal syndrome. Drug Alcohol Depend 21:253.
Sweet AY (1982) Narcotic withdrawal syndrome in the newborn. Pediatr Rev 3:285.
Johnstone RE, Lief PL, Kulp RA et al (1975) Combination of delta-9-tetrahydrocannabinol with oxymorphone and pentobarbital. Anesthesiology 42:674.
Stoelting RK, Martz RC, Gartner J et al (1973) Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs. Anesthesiology 38:521.
Parker H, Measham F, Aldridge J (1995) Drug futures. Changing patterns of drug use amongst English youth. Institute for the Study of Drug Dependence, London.
McMiller P, Plant M (1996) Drinking, smoking, and illicit drug use among 15 and 16 year olds in the United Kingdom. British Medical Journal 313:394–397.
Rudat K, Speed M, Ryan H (1992) Today’s young adults: 16’19-year-olds look at alcohol, smoking, drugs and sexual behaviour. Health Education Authority, London
Rudnick G, Wall SC (1992) The molecular mechanism of “ecstasy” [3,4-methylene-dioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA induced serotonin release. Proc Nat Acad Sci 89:1817–1821.
Fuller RW, Hines CW, Mills J (1965) Lowering of brain Serotonin level by Chloramphetamines. Biochem Pharmacol 14:483–488.
Pletscher A, Burkard WP, Brunderer H, Grey KF (1963) Decrease of cerebral 5-hydrox-ytryptamine and 5-hydroxyindolacetic acid by an arylalkylamine. Life Sciences 2:828–833.
Johnson MP, Hoffman AJ, Nichols DE (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H]dopamine release from the superfused rat brain slices. Eur J Pharmacol 132:269–276.
Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW (1982) Effects of certain hallucinogenic amphetamine analogues on the release of (3H) Serotonin from rat brain synaptosomes. J Med Chem 25:535–538.
Schmidt CJ, Levin JA, Lovenberg W (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36:747–755.
Clineschmidt BV, Totaro JA, McGuffin JC, Pflueger AB (1976) Fenfluramine: long-term reduction in brain Serotonin (5-hydroxytryptamine). Eur J Pharmacol 35:211–214.
Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C (1985) Hallucinogenic amphetamine selectively destroys brain serotonin terminals. Science 229:986–988.
McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4 methylenedioxymethamphetamine (MDMA, “ecstasy”). J Neurochem 54:14–22.
Dowling GP, McDonagh ET III, Bost RO (1987) Eve and Ecstasy. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257:1615–1617.
Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylene-dioxymethamphetamine (Ecstasy). Lancet 340:384–387.
Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL (1992) Hyperpyrexia and rhabdomyolysis after MDMA (ecstasy) abuse. Lancet 339:677–678.
Nimmo SM, Kennedy BW, Tullett WM, Blyth AS, Dougall JR (1993) Drug-induced hyperthermia. Anaesthesia 48:892–895.
Singarajah C, Lavies NG (1992) An overdose of ecstasy. A role for dantrolene. Anaesthesia 47:686–687.
Logan AS, Stickle B, O’Keefe N, Hewitson H (1993) Survival following ecstasy ingestion with a peak temperature of 42 degrees C. Anaesthesia 48:1017–1018.
Webb C, Williams V (1993) Ecstasy intoxication: appreciation of complications and the role of dantrolene. Anaesthesia 48:542–543.
Tehan B, Hardern R, Bodenham A (1993) Hyperthermia associated with 3,4-methyl-enedioxyethamphetamine (Eve). Anaesthesia 48:507–510.
Rhodes PJ, Rhodes RS (1984) Elimination kinetics and symptomatology of diazepam withdrawal in abusers. Clin Toxicol 22:371.
Marchant B, Wray R, Leach A, Nama M (1989) Flumazenil causing convulsions and ventricular tachycardia. Br Med J 299:860.
Shulgin AT (1980) LSD. J Psychedelic Drugs 12:173.
Khun DM, White FJ, Appel JB (1978) The discriminative stimulus properties of LSD: mechanisms of action. Neuropharmacology 17:257.
McCarron MM, Schulze BW, Thompson GA (1981) Acute phencyclidine intoxication: clinical patterns, complications and treatment. Ann Emerg Med 10:290.
Barton CH, Sterling ML, Vaziri ND (1981) Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. Ann Emerg Med 10:243
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Italia
About this chapter
Cite this chapter
Parr, M.J.A., Hadfield, R.J.H. (1999). Anaesthetic implications of drug abuse in trauma patients. In: Berlot, G., Delooz, H., Gullo, A. (eds) Trauma Operative Procedures. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-2151-8_15
Download citation
DOI: https://doi.org/10.1007/978-88-470-2151-8_15
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0045-2
Online ISBN: 978-88-470-2151-8
eBook Packages: Springer Book Archive